Production (Stage)
Avidity Biosciences, Inc.
RNA
$30.58
-$0.23-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.22% | -27.19% | -13.57% | -2.81% | -13.92% |
| Total Depreciation and Amortization | 6.37% | 3.94% | 3.35% | 7.18% | 4.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.59% | -3.17% | -11.94% | 12.07% | 9.98% |
| Change in Net Operating Assets | -277.15% | -202.63% | 247.94% | 60.74% | -115.01% |
| Cash from Operations | -24.99% | -52.21% | -0.94% | 7.64% | -526.52% |
| Capital Expenditure | 4.16% | -129.81% | -220.90% | 41.97% | -6.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 367.10% | 87.47% | -75.23% | -761.83% | -161.33% |
| Cash from Investing | 344.95% | 86.70% | -75.51% | -739.37% | -164.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -85.89% | -95.99% | -23.37% | 80.27% | 677.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -100.11% | -- |
| Cash from Financing | -85.89% | -95.99% | -23.34% | 14.71% | 1,121.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.84% | 26.87% | -292.38% | -62.68% | 187.95% |